Foundry Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-32,403	Closed	-$22.6M	–	347
2022 Q1	$22.6M	Sell	32,403 -715	-2%	-$499K	1.15%	26
2021 Q4	$20.9M	Buy	+33,118	New	+$20.9M	0.74%	40
2014 Q1	–	Sell	-15,860	Closed	-$4.37M	–	294
2013 Q4	$4.37M	Buy	+15,860	New	+$4.37M	0.39%	93